New State-of-the-Art Hybrid Operating Room Unveiled at MarinHealth Medical Center

Today, MarinHealth Medical Center unveiled its new hybrid operating room, a surgical suite that combines the best tools of a traditional operating setting with advanced imaging technology. It offers advanced technology to provide real-time images for guidance during complex cardiovascular and vascular…

Read MoreNew State-of-the-Art Hybrid Operating Room Unveiled at MarinHealth Medical Center

Exscientia receives grant from Open Philanthropy to explore a new therapeutic approach for pandemic influenza

Exscientia plc (Nasdaq: EXAI) today announced that it has received a $2.3 million grant from Open Philanthropy, a multi-program philanthropic funder in the field of global health and well-being. Under this grant, Exscientia intends to use activation of the host response…

Read MoreExscientia receives grant from Open Philanthropy to explore a new therapeutic approach for pandemic influenza

The Chuck Lorre Family Foundation Makes $10 Million Gift To Children’s Hospital Los Angeles To Support Research Education for Underrepresented High School and College Students

The Chuck Lorre Family Foundation Makes $10 Million Gift To Children’s Hospital Los Angeles To Support Research Education for Underrepresented High School and College Students The Chuck Lorre Family Foundation has pledged a total of $10 million to Children’s Hospital Los Angeles to support…

Read MoreThe Chuck Lorre Family Foundation Makes $10 Million Gift To Children’s Hospital Los Angeles To Support Research Education for Underrepresented High School and College Students

CG Oncology Receives Both FDA Fast Track and Breakthrough Therapy Designation for Cretostimogene Grenadenorepvec in High-Risk BCG-Unresponsive Non-Muscle Invasive Bladder Cancer

CG Oncology, Inc. today announced that the U.S. Food and Drug Administration (FDA) has granted both Fast Track Designation and Breakthrough Therapy Designation for cretostimogene grenadenorepvec in high-risk Bacillus Calmette-Guérin (BCG)-unresponsive Non-Muscle Invasive Bladder Cancer (NMIBC) with carcinoma in situ with or without…

Read MoreCG Oncology Receives Both FDA Fast Track and Breakthrough Therapy Designation for Cretostimogene Grenadenorepvec in High-Risk BCG-Unresponsive Non-Muscle Invasive Bladder Cancer

Novo Integrated Sciences Signs Master Collaboration Agreement with Psychocare Health Pvt. Ltd. India

Novo Integrated Sciences, Inc. (NASDAQ: NVOS) (the “Company” or “Novo”) proudly announces the signing of a Master Collaboration Agreement with Psychocare Health Pvt. Ltd. India (“PCHPL”). This partnership initiates a strategic initiative to introduce new products and state-of-the-art healthcare technologies…

Read MoreNovo Integrated Sciences Signs Master Collaboration Agreement with Psychocare Health Pvt. Ltd. India

Horus Pharma Is Strengthening Its International Expansion in Support of Its Growth

Horus Pharma, an independent French company leading player in ophthalmology, strengthens its international presence with the signature of eight distribution agreements – covering Romania, Portugal, Croatia, Turkey, Algeria, Qatar, Ireland and Bosnia – taking its total number of collaborations to 19. These…

Read MoreHorus Pharma Is Strengthening Its International Expansion in Support of Its Growth

The Largest Plastic Surgery Information Platform in South Korea Launches UNNI a Global K-Medical Information App for Foreigners

The Largest Plastic Surgery Information Platform in South Korea Launches ‘UNNI’, a Global K-Medical Information App for Foreigners Healing Paper, the operator of the largest plastic surgery information platform in South Korea, ‘Gangnam Unni’, announced that it launched ‘UNNI,’ a…

Read MoreThe Largest Plastic Surgery Information Platform in South Korea Launches UNNI a Global K-Medical Information App for Foreigners

STEMCELL Technologies Wins a Canada’s Most Admired Corporate Cultures™ of 2023 Award

STEMCELL Technologies, Canada’s largest biotechnology company, has received the Canada’s Most Admired Corporate Cultures™ of 2023 award by Waterstone Human Capital. This national awards program recognizes best-in-class Canadian organizations for fostering high-performance corporate cultures that help sustain a competitive advantage. “Being…

Read MoreSTEMCELL Technologies Wins a Canada’s Most Admired Corporate Cultures™ of 2023 Award

Vertex Announces European Medicines Agency Validation for Marketing Authorization Application Extension for KAFTRIO® in Combination With Ivacaftor to Include People With Cystic Fibrosis and Responsive Rare Mutations

Vertex Pharmaceuticals (Nasdaq: VRTX) today announced that the European Medicines Agency (EMA) has validated a Type II variation application to the Marketing Authorization for KAFTRIO® (ivacaftor/tezacaftor/elexacaftor) in combination with ivacaftor. The application is for expansion of the approved indication for KAFTRIO® in a…

Read MoreVertex Announces European Medicines Agency Validation for Marketing Authorization Application Extension for KAFTRIO® in Combination With Ivacaftor to Include People With Cystic Fibrosis and Responsive Rare Mutations

Boehringer Ingelheim receives approval for SENVELGO® in Europe: the first oral liquid medication for diabetic cats

Boehringer Ingelheim, a global leader in animal health, has received marketing authorization from the European Commission for SENVELGO® (active ingredient: velagliflozin), marking a significant step for the treatment of feline diabetes in Europe. Globally, SENVELGO® is the first once-daily liquid oral solution…

Read MoreBoehringer Ingelheim receives approval for SENVELGO® in Europe: the first oral liquid medication for diabetic cats